Eastman Chemical (NYSE: EMN) grants options and RSUs to SVP

Rhea-AI Filing Summary

Gbadegesin Bosede Ikeolu reported acquisition or exercise transactions in this Form 4 filing.

Eastman Chemical Company senior vice president, chief legal officer and corporate secretary Bosede Ikeolu Gbadegesin received equity awards as part of compensation. She was granted employee stock options for 33,223 shares on February 24, 2026, with one‑third becoming exercisable on February 24 of 2027, 2028 and 2029.

She also received 4,571 restricted stock units on the same date. Each unit represents the right to receive one share of common stock, and these RSUs vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Gbadegesin Bosede Ikeolu

Role SVP, CLO & Corporate Secretary

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	33,223	$0.00	--
Grant/Award	Restricted Stock Units	4,571	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 33,223 shares (Direct); Restricted Stock Units — 4,571 shares (Direct)

Footnotes (1)

1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gbadegesin Bosede Ikeolu

(Last) (First) (Middle)

200 SOUTH WILCOX DRIVE

(Street)

KINGSPORT TN 37664

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CLO & Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$77.12	02/24/2026		A		33,223		02/24/2027(1)	02/23/2036	Common Stock	33,223	$0	33,223	D
Restricted Stock Units	(2)	02/24/2026		A		4,571		(3)	(3)	Common Stock	4,571	$0	4,571	D

Explanation of Responses:

1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.

2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.

3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

Remarks:

	//Mark D. Austin, by Power of Attorney for Bosede Ikeolu Gbadegesin	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Eastman Chemical (EMN) report for Bosede Ikeolu Gbadegesin?

Eastman Chemical reported that Bosede Ikeolu Gbadegesin received equity awards, including stock options and restricted stock units, on February 24, 2026. These are compensation-related grants rather than open-market purchases or sales, and they vest over several years according to specified schedules.

How many stock options were granted to the Eastman Chemical (EMN) executive?

Bosede Ikeolu Gbadegesin was granted 33,223 employee stock options on February 24, 2026. One-third of these options become exercisable on February 24 of 2027, 2028, and 2029, creating a three-year vesting schedule tied to ongoing service with Eastman Chemical.

What restricted stock units did the Eastman Chemical (EMN) executive receive?

She received 4,571 restricted stock units on February 24, 2026. Each unit represents a contingent right to one share of Eastman Chemical common stock, with all units scheduled to vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.

When do the Eastman Chemical (EMN) stock options for Bosede Ikeolu Gbadegesin vest?

Her 33,223 stock options vest in three equal installments. One-third becomes exercisable on February 24, 2027, another third on February 24, 2028, and the final third on February 24, 2029, aligning vesting with multi-year service at Eastman Chemical.

When will the Eastman Chemical (EMN) restricted stock units for this executive vest?

The 4,571 restricted stock units vest and pay out on February 24, 2029. At that time, subject to continued employment, they convert into unrestricted shares of Eastman Chemical common stock, providing long-term, stock-based compensation alignment for the executive.

Is the Form 4 for Eastman Chemical (EMN) a stock sale or a grant to the executive?

The Form 4 reflects grants to the executive, not sales. Bosede Ikeolu Gbadegesin acquired stock options and restricted stock units as part of compensation on February 24, 2026, with vesting conditions rather than immediate cash transactions in the open market.